BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 1999
View Archived Issues
York Medical: Annual Report 1998
Read More
U.S. patent issues to Washington University for mammaglobin
Read More
Steroidogenesis Inhibitors to begin satellite open clinical studies in multiple indications
Read More
Synvisc relieves pain, delays need for total knee replacement in osteoarthritis
Read More
Cubist enters agreement with Novartis for antiinfective drug discovery
Read More
Pierre Fabre Dermatologie to commercialize Allergan's Zorac in Europe
Read More
Positive preclinical results for NuChem's anticancer compounds in lung cancer model
Read More
InSite Vision updates shareholders
Read More
PSP94 suppresses prostate cancer growth in mouse model
Read More
Rosetta and Acacia announce intention to merge
Read More
Abbott makes milestone payments to Aronex for antifungal drug Nyotran
Read More
Orally bioavailable tachykinin antagonists from MS&D for emesis, etc.
Read More
Biota's flu drug gets first approval
Read More
Astra describes N-type neuronal calcium channel blockers and their use
Read More
Good safety, increased immunogenicity reported for MF59-adjuvanted flu vaccine
Read More
Neurogen and Pfizer collaborate on development of NPY receptor ligands
Read More
New antiinflammatory/immunomodulatory compounds from Signal act at a transcriptional level
Read More
New compounds from Novo Nordisk for pain, inflammation, diabetes
Read More
Kanebo to be acquired by Organon, merged into Nippon Organon
Read More
Mitsubishi antidepressant to be codeveloped by Taisho
Read More
Glaxo presents new NNRTI from quinoxaline class that has progressed to human trials
Read More
T-140, a potent CXCR4-dependent inhibitor of HIV infection
Read More
Pediatric study supports use of vCP205 in infants born to HIV-positive mothers
Read More
Bristol-Myers Squibb suspends clinical studies of lobucavir
Read More
Celebrex receives approval in Mexico
Read More
Broad patent issues for Avigen's AAV vectors
Read More